Steris PLC (STE)
199.56
-1.26
(-0.62%)
USD |
NYSE |
Apr 19, 16:00
199.56
0.00 (0.00%)
After-Hours: 20:00
Steris Cash from Financing (Quarterly): -197.99M for Dec. 31, 2023
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | -197.99M |
September 30, 2023 | 470.21M |
June 30, 2023 | -213.64M |
March 31, 2023 | -191.95M |
December 31, 2022 | -120.41M |
September 30, 2022 | -44.95M |
June 30, 2022 | -141.41M |
March 31, 2022 | -274.61M |
December 31, 2021 | -189.26M |
September 30, 2021 | -239.11M |
June 30, 2021 | 818.81M |
March 31, 2021 | -96.91M |
December 31, 2020 | 641.85M |
September 30, 2020 | -65.32M |
June 30, 2020 | -134.00M |
March 31, 2020 | -9.272M |
December 31, 2019 | -90.34M |
September 30, 2019 | -55.92M |
June 30, 2019 | -7.607M |
March 31, 2019 | -110.98M |
December 31, 2018 | -43.95M |
September 30, 2018 | -100.65M |
June 30, 2018 | -39.21M |
March 31, 2018 | -160.37M |
December 31, 2017 | -76.47M |
Date | Value |
---|---|
September 30, 2017 | -97.09M |
June 30, 2017 | -22.25M |
March 31, 2017 | -58.51M |
December 31, 2016 | -46.98M |
September 30, 2016 | -118.60M |
June 30, 2016 | -43.01M |
March 31, 2016 | -92.83M |
December 31, 2015 | 474.22M |
September 30, 2015 | 128.66M |
June 30, 2015 | 50.23M |
March 31, 2015 | -8.328M |
December 31, 2014 | -30.02M |
September 30, 2014 | -50.36M |
June 30, 2014 | 158.47M |
March 31, 2014 | 8.891M |
December 31, 2013 | -47.61M |
September 30, 2013 | -30.04M |
June 30, 2013 | 14.55M |
March 31, 2013 | -31.80M |
December 31, 2012 | 71.86M |
September 30, 2012 | 221.19M |
June 30, 2012 | -7.002M |
March 31, 2012 | -7.137M |
December 31, 2011 | -22.25M |
September 30, 2011 | -46.71M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-274.61M
Minimum
Mar 2022
818.81M
Maximum
Jun 2021
-7.465M
Average
-96.91M
Median
Mar 2021
Cash from Financing (Quarterly) Benchmarks
Edwards Lifesciences Corp | -413.20M |
Stryker Corp | -286.00M |
Align Technology Inc | -350.28M |
ThermoGenesis Holdings Inc | 0.217M |
Nutriband Inc | -0.005M |
Cash from Financing (Quarterly) Related Metrics
Cash from Operations (Quarterly) | 291.24M |
Cash from Investing (Quarterly) | -118.92M |
Free Cash Flow | 593.99M |
Free Cash Flow Per Share (Quarterly) | 1.734 |
Free Cash Flow to Equity (Quarterly) | 299.97M |
Free Cash Flow to Firm (Quarterly) | 201.29M |
Free Cash Flow Yield | 2.98% |